ARCH Venture Management, LLC Diversified Active

Location: Chicago, IL

CIK: 0001274403 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 27, 2022

Total Value: $700M (100.0% shares, 0.0% debt)

Holdings (8)

— KARUNA THERAPEUTICS, INC. 52.8%

Value $369M Shares 2,912,872 Est. Cost $131.00 Unrealized —

— EQRX, INC. 21.4%

Value $150M Shares 36,335,375 Est. Cost $6.82 Unrealized —

ERAS ERASCA, INC. 13.6%

Value $95.08M Shares 11,055,554 Est. Cost $17.12 Unrealized -32.3%

— VERVE THERAPEUTICS, INC. 8.2%

Value $57.25M Shares 2,508,809 Est. Cost $36.87 Unrealized —

— SINGULAR GENOMICS SYSTEMS, INC. 3.4%

Value $23.97M Shares 3,798,926 Est. Cost $11.56 Unrealized —

— RUBIUS THERAPEUTICS, INC. 0.3%

Value $1.928M Shares 349,908 Est. Cost $16.08 Unrealized —

— METACRINE, INC. 0.3%

Value $1.793M Shares 2,940,503 Est. Cost $0.61 Unrealized —

— ZYMERGEN INC. 0.0%

Value $345K Shares 119,205 Est. Cost $6.69 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS, INC.	2,912,872	$369M	52.8%	$131.00	—	COM	48576A100
—	EQRX, INC.	36,335,375	$150M	21.4%	$6.82	—	COM	26886C107
ERAS	ERASCA, INC.	11,055,554	$95.08M	13.6%	$17.12	-32.3%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,508,809	$57.25M	8.2%	$36.87	—	COM	92539P101
—	SINGULAR GENOMICS SYSTEMS, INC.	3,798,926	$23.97M	3.4%	$11.56	—	COM	82933R100
—	RUBIUS THERAPEUTICS, INC.	349,908	$1.928M	0.3%	$16.08	—	COM	78116T103
—	METACRINE, INC.	2,940,503	$1.793M	0.3%	$0.61	—	COM	59101E103
—	ZYMERGEN INC.	119,205	$345K	0.0%	$6.69	—	COM	98985X100